SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-102226
Filing Date
2018-03-29
Accepted
2018-03-29 17:21:28
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d529745ds3.htm S-3 280115
2 EX-4.1 d529745dex41.htm EX-4.1 549859
3 EX-4.2 d529745dex42.htm EX-4.2 602240
4 EX-5.1 d529745dex51.htm EX-5.1 33620
5 EX-23.1 d529745dex231.htm EX-23.1 1889
6 GRAPHIC g529745g0329105111910.jpg GRAPHIC 2565
7 GRAPHIC g529745g37v96.jpg GRAPHIC 3283
  Complete submission text file 0001193125-18-102226.txt   1477074
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-224031 | Film No.: 18723998
SIC: 2834 Pharmaceutical Preparations